Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Seagen Inc.
Hoffmann-La Roche
City of Hope Medical Center
M.D. Anderson Cancer Center
Mayo Clinic